Dr. Bruno Paiva receives an runner-up award at the 60th Anniversary Farmaindustria Young Researchers Awards

Dr. Bruno Paiva, director of the Myeloma Group of the Cima University of Navarra, was distinguished for his research focused on hematology and monoclonal gammopathies, with a special focus on multiple myeloma

Dr. Paiva, fourth from the left, during the Farmaindustria Young Researchers Awards Ceremony.

April 22, 2024

Researchers, patients, representatives of the healthcare and pharmaceutical world and authorities gathered  at a gala held at the Círculo de Bellas Artes in Madrid to celebrate 60 years of work by Farmaindustria as a representative institution of innovative pharmaceutical companies based in Spain. 

During the gala, the 60th Anniversary Farmaindustria Young Researchers Awards were presented. The members of the Evaluation Committee awarded the prize to Dr. Cristina Mayor-Ruiz, from IRB Barcelona, for "her impeccable academic and scientific development, her translational approach and the disruptive nature of her research in the search for new treatments for different types of cancer". 

Likewise, four runner-up prizes were awarded to the profiles with the highest merits. Dr. Bruno Paiva, director of the Myeloma Group of the Cima University of Navarra, integrated in the Cancer Center Clínica Universidad de Navarra, was distinguished for his research focused on hematology and monoclonal gammopathies, with a special focus on multiple myeloma. Other scientists awarded were Dr. Arnau Busquets García, from the Hospital del Mar Research Institute; Dr. Pilar Domingo Calap, from the Institute for Integrative Systems Biology (i2SysBio); and Dr. Alfonso de Oyarzábal Sanz, from the Hospital Sant Joan de Déu in Barcelona.

The Committee highlighted the difficulty in choosing the award winners from among the 20 finalists and the 113 nominations received, all of which were of an excellent level, confirming the great pool of young talent that exists in Spanish biomedical research.

The closing ceremony was attended by the Secretary of State for Science, Innovation and Universities, Juan Cruz Cigudosa, who emphasized that Spain is "a country that looks to biomedical innovation as an engine of economic and social development".